Anika Therapeutics Revenue 2006-2021 | ANIK

Anika Therapeutics revenue from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Anika Therapeutics Annual Revenue
(Millions of US $)
2020 $130
2019 $115
2018 $106
2017 $113
2016 $103
2015 $93
2014 $106
2013 $75
2012 $71
2011 $65
2010 $56
2009 $40
2008 $36
2007 $31
2006 $27
2005 $30
Anika Therapeutics Quarterly Revenue
(Millions of US $)
2021-09-30 $40
2021-06-30 $38
2021-03-31 $34
2020-12-31 $33
2020-09-30 $32
2020-06-30 $31
2020-03-31 $35
2019-12-31 $30
2019-09-30 $30
2019-06-30 $30
2019-03-31 $25
2018-12-31 $27
2018-09-30 $27
2018-06-30 $31
2018-03-31 $21
2017-12-31 $29
2017-09-30 $27
2017-06-30 $33
2017-03-31 $23
2016-12-31 $29
2016-09-30 $26
2016-06-30 $27
2016-03-31 $22
2015-12-31 $31
2015-09-30 $24
2015-06-30 $23
2015-03-31 $16
2014-12-31 $23
2014-09-30 $22
2014-06-30 $26
2014-03-31 $34
2013-12-31 $21
2013-09-30 $18
2013-06-30 $21
2013-03-31 $15
2012-12-31 $23
2012-09-30 $15
2012-06-30 $20
2012-03-31 $14
2011-12-31 $18
2011-09-30 $18
2011-06-30 $16
2011-03-31 $12
2010-12-31 $15
2010-09-30 $14
2010-06-30 $15
2010-03-31 $12
2009-12-31 $11
2009-09-30 $11
2009-06-30 $10
2009-03-31 $9
2008-12-31 $9
2008-09-30 $9
2008-06-30 $9
2008-03-31 $9
2007-12-31 $10
2007-09-30 $8
2007-06-30 $7
2007-03-31 $6
2006-12-31 $6
2006-09-30 $6
2006-06-30 $8
2006-03-31 $7
2005-12-31 $5
2005-09-30 $10
2005-06-30 $7
2005-03-31 $7
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.462B $0.130B
Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.036B 8.91
Bio-Rad Laboratories (BIO.B) United States $17.472B 35.46
QIAGEN (QGEN) Netherlands $11.101B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.210B 0.00
Emergent Biosolutions (EBS) United States $2.527B 9.09
Arcus Biosciences (RCUS) United States $2.184B 0.00
Myovant Sciences (MYOV) United Kingdom $1.260B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.080B 0.00
Zymeworks (ZYME) Canada $0.522B 0.00
SQZ Biotechnologies (SQZ) United States $0.201B 0.00
Ambrx Biopharma (AMAM) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81